Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 8 studies | 24% ± 8% | |
macrophage | 7 studies | 23% ± 8% | |
enterocyte | 5 studies | 28% ± 9% | |
non-classical monocyte | 4 studies | 22% ± 2% | |
epithelial cell of proximal tubule | 3 studies | 25% ± 7% | |
epithelial cell | 3 studies | 25% ± 10% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 3 studies | 20% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1703.29 | 244 / 245 | 99% | 49.03 | 499 / 502 |
liver | 100% | 1649.70 | 226 / 226 | 98% | 44.42 | 398 / 406 |
kidney | 100% | 1180.33 | 89 / 89 | 98% | 105.69 | 881 / 901 |
pancreas | 100% | 1031.88 | 328 / 328 | 96% | 24.40 | 171 / 178 |
thymus | 99% | 721.19 | 644 / 653 | 97% | 26.08 | 586 / 605 |
lung | 99% | 1363.14 | 570 / 578 | 94% | 32.33 | 1081 / 1155 |
stomach | 95% | 1038.03 | 342 / 359 | 96% | 29.14 | 275 / 286 |
breast | 99% | 1018.81 | 453 / 459 | 91% | 20.44 | 1012 / 1118 |
intestine | 92% | 2724.33 | 891 / 966 | 95% | 26.80 | 503 / 527 |
skin | 100% | 3660.49 | 1808 / 1809 | 86% | 19.54 | 404 / 472 |
esophagus | 90% | 691.87 | 1303 / 1445 | 95% | 24.53 | 173 / 183 |
bladder | 95% | 1630.81 | 20 / 21 | 83% | 19.57 | 417 / 504 |
uterus | 99% | 1713.55 | 168 / 170 | 76% | 17.83 | 351 / 459 |
adrenal gland | 100% | 1947.61 | 258 / 258 | 67% | 17.89 | 155 / 230 |
brain | 67% | 415.60 | 1783 / 2642 | 87% | 13.09 | 615 / 705 |
ovary | 97% | 715.13 | 175 / 180 | 27% | 3.07 | 118 / 430 |
muscle | 100% | 2133.52 | 802 / 803 | 0% | 0 | 0 / 0 |
spleen | 99% | 1895.63 | 239 / 241 | 0% | 0 | 0 / 0 |
adipose | 97% | 854.51 | 1168 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 30.51 | 28 / 29 |
tonsil | 0% | 0 | 0 / 0 | 87% | 21.72 | 39 / 45 |
heart | 54% | 246.25 | 461 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 49% | 285.49 | 648 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 44% | 4.93 | 35 / 80 |
peripheral blood | 43% | 499.96 | 399 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006685 | Biological process | sphingomyelin catabolic process |
GO_0009143 | Biological process | nucleoside triphosphate catabolic process |
GO_0005615 | Cellular component | extracellular space |
GO_0070062 | Cellular component | extracellular exosome |
GO_0004767 | Molecular function | sphingomyelin phosphodiesterase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0008081 | Molecular function | phosphoric diester hydrolase activity |
Gene name | SMPDL3A |
Protein name | Cyclic GMP-AMP phosphodiesterase SMPDL3A (2',3'-cGAMP phosphodiesterase SMPDL3A) (EC 3.1.4.-) (Acid sphingomyelinase-like phosphodiesterase 3a) (ASM-like phosphodiesterase 3a) (EC 3.6.1.15) |
Synonyms | ASML3A |
Description | FUNCTION: Cyclic-nucleotide phosphodiesterase that acts as a negative regulator of innate immunity by mediating degradation of 2',3'-cGAMP, thereby inhibiting the cGAS-STING signaling . Specifically linearizes 2',3'-cGAMP into 2'5'-bond pGpA and further hydrolyzes pGpA to produce GpA . Also has in vitro nucleotide phosphodiesterase activity with nucleoside triphosphates, such as ATP . Has in vitro activity with p-nitrophenyl-TMP . Has lower activity with nucleoside diphosphates, and no activity with nucleoside monophosphates . Has in vitro activity with CDP-choline, giving rise to CMP and phosphocholine. Has in vitro activity with CDP-ethanolamine . Does not have sphingomyelin phosphodiesterase activity . . |
Accessions | Q92484 ENST00000539041.5 [Q92484-2] ENST00000368440.5 [Q92484-1] |